The Role of TLRs in Obesity and Its Related Metabolic Disorders
International Journal of Molecular Sciences · 01.03.2025 · 26 (5) · 2229
DOI: 10.3390/ijms26052229 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.03.2025. Verfasst von Tannia Isabel Campos-Bayardo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University Center of Health Sciences, University of Guadalajara, Guadalajara 44360, Jalisco, Mexico. Hauptthemen laut MEDLINE: Obesity, Toll-Like Receptors, Metabolic Diseases. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity affects the adaptability of adipose tissue (AT), impairing its ability to regulate energy and metabolism. Obesity is associated with many metabolic disorders, including dyslipidemia, hypertension, sleep disorders, non-alcoholic liver disease, and some types of cancer. Toll-like receptors (TLRs) are important in obesity and related metabolic disorders. TLRs are pattern-recognizing receptors (PRRs) involved in the innate immune system and recognize pathogen-associated molecular patterns (PAMPs) and endogenous ligands. TLRs, especially TLR2 and TLR4, are activated by fatty acids, endotoxins, and other ligands. TLR2 and TLR4 activation triggers inflammatory responses. Chronic inflammation driven by TLR activation is a hallmark of obesity and metabolic diseases. The inflammatory response triggered by TLR activation alters insulin signaling, contributing to insulin resistance, a key feature of metabolic syndrome and type 2 diabetes. Modulation of TLR activity through lifestyle changes (diet and exercise), obesity surgery, and pharmacological agents is under study as a possible therapeutic approach to controlling obesity and its complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University Center of Health Sciences, University of Guadalajara, Guadalajara 44360, Jalisco, Mexico.
- Department of Laparoscopic Surgery, Hospital Civil de Guadalajara, "Juan I Menchaca", Guadalajara 44360, Jalisco, Mexico.
- Department of Nephrology, National Medical Center of the West, Mexican Social Security Institute, Guadalajara 44340, Jalisco, Mexico.
- Department of Molecular Biology and Genomics, Institute of Nutrigenetics and Translational Nutrigenomics, University of Guadalajara, Guadalajara 44340, Jalisco, Mexico.
ORCID-Profile: Tannia Isabel Campos-Bayardo, Daniel Román-Rojas, Andrés García-Sánchez, Ernesto Germán Cardona-Muñoz, Jorge Andrade-Sierra, Leonardo Pazarín-Villaseñor, Wendy Campos-Pérez, Erika Martínez-López, Alejandra Guillermina Miranda-Díaz
Zitieren
APA
Campos-Bayardo, T. I., Román-Rojas, D., García-Sánchez, A., Cardona-Muñoz, E. G., Sánchez-Lozano, D. I., Totsuka-Sutto, S., Gómez-Hermosillo, L. F., Casillas-Moreno, J., Andrade-Sierra, J., Pazarín-Villaseñor, L., Campos-Pérez, W., Martínez-López, E., & Miranda-Díaz, A. G. (2025). The Role of TLRs in Obesity and Its Related Metabolic Disorders. International Journal of Molecular Sciences, 26(5), 2229. https://doi.org/10.3390/ijms26052229
Vancouver
Campos-Bayardo TI, Román-Rojas D, García-Sánchez A, Cardona-Muñoz EG, Sánchez-Lozano DI, Totsuka-Sutto S, et al. The Role of TLRs in Obesity and Its Related Metabolic Disorders. International Journal of Molecular Sciences. 2025;26(5):2229. doi:10.3390/ijms26052229
BibTeX
@article{CamposBayardo2025,
author = {Campos-Bayardo, Tannia Isabel and Román-Rojas, Daniel and García-Sánchez, Andrés and Cardona-Muñoz, Ernesto Germán and Sánchez-Lozano, Daniela Itzel and Totsuka-Sutto, Sylvia and Gómez-Hermosillo, Luis Francisco and Casillas-Moreno, Jorge and Andrade-Sierra, Jorge and Pazarín-Villaseñor, Leonardo and Campos-Pérez, Wendy and Martínez-López, Erika and Miranda-Díaz, Alejandra Guillermina},
title = {The Role of TLRs in Obesity and Its Related Metabolic Disorders},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {2229},
doi = {10.3390/ijms26052229}
}
EUVIMED